The Success Rate of Cryotherapy Application in Primary Molars With Signs of Irreversible Pulpitis

Minia University188 enrolled

Overview

The study is designed as a randomized controlled trial with two parallel groups. Children aged 5-9 years with primary molars from suffered symptomatic signs of irreversible pulpitis will be randomly assigned into two groups. The first group (experimental group) will be injected with 4% articaine 1:100.000 epinephrine (inferior alveolar nerve block). For the second group, the mandibular second primary molars will be anesthetized using 4% articaine 1:100.000 epinephrine using inferior alveolar nerve block.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

SINGLE

Enrollment

188

Conditions

Pain, Procedural

Interventions

CryotherapyOTHER

local anesthetic injection with articaine 4% 1:100,000 epinephrine then an application ice packs

Traditional local anesthesiaOTHER

local anesthetic injection with articaine 4% 1:100,000 epinephrine

Eligibility

Sex: ALLMin age: 5 YearsMax age: 9 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Healthy children are classified as I or II according to ASA * Presence of at least one mandibular primary molar with symptomatic signs of irreversible pulpitis * Presence of at least two-thirds of the root length in periapical radiograph Exclusion Criteria: * Unrestorable crowns * Children with systemic, severe behavior or emotional problems * Presence of gingival redness, swellings, fistulous of sinus tract * Radiographic evidence of internal root resorption, pulp stones or calcifications, and/or bone radiolucency

Locations (1)

Omar Ahmed

Al Minyā, Egypt

RECRUITING

Outcomes

Primary Outcomes

Pain assessment

Wong Backer pain scale

Time frame: up to 24 hours

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.